Nine Drugmakers Agree To Trump’s ‘Most-Favored-Nation’ Pricing Deal
The deal requires the pharmaceutical companies to match what they charge in other developed countries for newly launched medications, including in commercial and cash-pay markets, as well as Medicare and Medicaid.